Morich Frank
Insider CIK 1748615 · CUE Director · ISR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics, | A Award deriv | 2026-03-02 | 2026-03-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 24,400 | — | $0 | 24,400 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2025-03-03 | 2025-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2024-06-20 | 2024-06-24 | 23,000 | — | $0 | 23,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 24,400 | — | $0 | 24,400 | SEC↗ |
| CATX Perspective Therapeutics, | A Award deriv | 2023-12-12 | 2023-12-14 | 230,000 | — | $0 | 2,037,471 | SEC↗ |
| ISR Perspective Therapeutics, | A Award deriv | 2023-02-21 | 2023-02-23 | 470,000 | — | $0 | 1,577,471 | SEC↗ |
| ISR Perspective Therapeutics, | A Award deriv | 2023-02-21 | 2023-02-23 | 230,000 | — | $0 | 1,807,471 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | P Buy | 2022-05-27 | 2022-05-31 | 28,000 | $3.75 | $105.0K | 28,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2020-05-11 | 2020-05-12 | 1,200 | — | $0 | 1,200 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2019-01-02 | 2019-01-03 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2018-07-31 | 2018-08-02 | 50,000 | — | $0 | 50,000 | SEC↗ |